Assessment of bone metabolism in obese women

Endocrine Regulations

Volumn 32, Issue 4, 1998, Pages 177-181

  Ostrowska, Z ^a   Zwirska Korczala, K ^b   Buntner, B ^b   Pardela, M ^b   Drozdz, M ^b  

^a Silesian University of Medical Sciences   (Poland)

^b NONE

Author keywords

Android phenotype; Bone metabolism; Extremely obese women

Indexed keywords

EID: 1442344918     PISSN: 12100668     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. ADACHI JD, BENSEN WG, HODSMAN AB: Corticosteroid-induced osteoporosis. Sem Arthrit Rheumat 22, 375-384, 1993
2. ANDERSEN T, MC NAIR P, FOGH-ANDERSEN N, NIELSEN TT, HYLDSTRUP L, TRANSBOL I: Increased parathyroid hormone as a consequence of changed complex binding of plasma calcium in morbid obesity. Metabolism 35, 147-151, 1986
3. BARANOWSKA B:Endocrine disorders in obesity. Pol Tyg Lek, Suppl. 1, 26-28, 1995 (in Polish)
4. BELL NH, EPSTEIN S, GREEN A, SHARY J, OEXMANN MJ, SHAW S: Evidence for alteration of the vitamin D-endocrine system in obese subjects. J Clin Invest 76, 370-373, 1985
5. BODEN SD, KAPLAN FS: Calcium homeostasis. Orthop Clin North Am 21, 31-42, 1990
6. BRIXEN K, KASSEM M, ERIKSEN EF, NIELSEN HK, FLYVBJERG A, MOSEKILDE L: Growth hormone (GH) and adult bone remodeling: the potential use of GH in treatment of osteoporosis. J Pediat Endocrin 6, 65-71, 1993
7. CAULEY JA, GUTAI JP, KULLER LH, SCOTT J, NEVITT MC: Black-white difference in serum sex hormones and bone mineral density. Am J Epidemiol 139, 1035-1046, 1994
8. CENTRELLA M, MC CARTY TL, CANALIS E: Glucocorticoid regulation of transforming growth factor beta 1 activity and binding in osteoblast-enriched cultures from fetal rat bone. Mol Cell Biol 11, 4490-4496, 1991
9. COMPSTON JE, VEDI S, LEDGER JE, WEEB A, GAZET JC, PILKINGTON TE: Vitamin D status and bone histomorphometry in gross obesity. Am J Clin Nutr 34, 2359-2363, 1981
10. DAVIE MW, ABRAHAM RR, HEWINS B, WYNN V: Changes in bone and muscle constituents during dieting for obesity. Clin Sci 70, 285-293, 1986
11. DE LUCA HF: New concepts of vitamin D functions. Ann New York Acad Sci 669, 59-69, 1992
12. DROBNIK J, DABROWSKI R: The effect of melatonin, continuous darkness and pinealectomy on both total and soluble collagens, as well as glycosaminoglycans levels in the wounds of rats. Endocrin Pol 44 (Suppl 1), pp 47, 1993
13. ERIKSEN EF, CHARLES P, MELSON F, MOSEKILDE L, RISTELI L, RISTELI J: Serum markers of type I collagen formation and degradation in metabolic bone disease. Correlation to bone histomorphometry. J Bone Miner Res 8, 127-132, 1993
14. ERNST M, RODAN GA: Estradiol regulation of insulin-like growth factor-I expression in osteoblast cells for transcriptional control. Mol Endocrin 5, 1081-1089, 1991
15. GLASS AR: Endocrine aspects of obesity. Med Clin North Am 73, 139-160, 1989
16. HAFFNER SM, BAUER RL: Excess androgenicity only partially explains the relationship between obesity and bone density in premenopausal women. Int J Obes Relat Metab Disord 16, 869-874, 1992
17. HASLING C, ERIKSEN EF, MELKKO J, RISTELI L, CHARLES P, MOSEKILDE L, RISTELI J: Effects of a combined estrogen-gestagen regimen on serum levels of the carboxyterminal propeptide of human type I procollagen in osteoporosis. J Bone Miner Res 6, 1295-1300, 1991
18. JOHNSTON CC, HUI SL, LONGCOPE C: Bone mass and sex steroid concentrations in postmenopausal Causian diabetics. Metabolism 34, 544-550, 1985
19. KROLNER B, RANLOV PJ, CLEMMENSEN T, PORS NIELSEN S: Bone loss after gastroplasty for morbid obesity: side effect or adaptative response to weight reduction? Lancet 25, 956-958, 1982
20. LIEL Y, ULMER E, SHARY J, HOLLIS BW, BELL NH: Low circulating vitamin D in obesity. Calcif Tissue Internat 43, 199-201, 1988
21. LISSOS TW, BENO DW, DAVIS BH: Posttranslational inhibition of I to cell type I collagen production by triiodothyronine. Am J Physiol 264, G1090-G1095, 1993
22. MARTIN TJ, MOSLEY JM: Calcitonin. In: Metabolic Bone Disease (Ed. LV Avioli, SM Krane) Philadelphia, WB Saunders, pp 131-154, 1990
23. MOSEKILDE L, MELSEN I, HESSOV I, CHRISTENSEN MS, LUND BJ, SORENSEN OH: Low serum levels of 1,25-dihydroxyvitamin D and histomorphometric evidence of osteomalacia after jejunoileal bypass for obesity. Gut 21, 624-631, 1980
24. NAGANT DE DEUXCHAINES C, DEVOGELAER JP: Endocrinological states of postmenopausal osteoporosis. Clin Rheumatol Dis 12, 559-635, 1986
25. NISHIMURA S: Role of testosterone propionate and insulin in the regeneration and growth of bone. Mekai Daigaku Shigaku Zasshi 19, 291-309, 1990
26. OIKARINEN A, AUTIO P, VUORI J, VAANANEN K, RISTELI L, KUSTALA U, RISTELI J: Systemic glucocorticoid treatment decreases serum concentrations of carboxyterminal propeptide of type I procollagen and aminoterminal propeptide of type III procollagen. Br J Dermatol 126, 172-178, 1992
27. OSTROWSKA Z, BUNTNER B, PARDELA M, DROZDZ M, ZWIRSKA-KORCZALA K: Circadian variations of norepinephrine and epinephrine in hypertensive and normotensive obese women. Endocrin Regul 31, 29-35, 1997a
28. OSTROWSKA Z, BUNTNER B, ZWIRSKA-KORCZALA K, MAREK B, NOWAK M: Circadian oscillations of melatonin, gonadotropins, sex hormones and SHBG in post-menopausal women showing androidal- and gynoidal obesity. Endocrin Regul 30, 133-141, 1996 a
29. OSTROWSKA Z, BUNTNER B, ZWIRSKA-KORCZALA K, PARDELA M, DROZDZ M, MAREK B: Assessment of α-endorphin and melatonin circadian rhythms in normotensive obese women of reproductive age. Endocrin Regul 31, 193-200, 1997b
30. OSTROWSKA Z, BUNTNER B, ZWIRSKA-KORCZALA K, PARDELA M, MAREK B, DROZDZ M: Association between pituitary ovarian axis function and melatonin secretion during day/night cycle in morbidly obese women with upper body obesity and menstrual disturbances before and after jejunoileostomy. Bull Pol Ac Biol 43, 85-97, 1995
31. OSTROWSKA Z, BUNTNER B, ZWIRSKA-KORCZALA K, SWIȨTOCHOWSKA E, SPYRA Z: Circadian variations of norepinephrine and melatonin in extremely obese men and women. Endocrin Regul 30, 19-27, 1996b
32. OSTROWSKA Z, SWIȨTOCHOWSKA E, ZWIRSKA-KORCZALA K, BUNTNER B, MAREK B, PARDELA M, DROZDZ M: Assessment of the relationship between collagen metabolism and selected hormonal factors in extremely obese women before and after surgical treatment by jejunoileostomy. Endocrin Regul 31, 55-61, 1997c
33. REITER RJ: Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocrine Rev 12, 151-180, 1991
34. RIBOT C, TREMOLLIERES F, POUILLES JM, BONEU M., GERMAIN F, LOUVET JP: Obesity and postmenopausal bone loss; the influence of obesity on vertebral density and bone turnover in postmenopausal women. Bone 8, 327-331, 1988
35. RIZZOLI R, FERRARI SL, PIZURKI L, CAVERZASIO J, BONJOUR JP: Actions of parathyroid hormone and parathyroid hormone-related protein. J Endocrin Invest 15 (Suppl 6), 51-56, 1992
36. SANDYK R, ANASTASIADIS PG, ANNIMOS PA, TSAGAS N: Is postmenopausal osteoporosis related to pineal gland functions? Int J Neurose 62, 215-225, 1992
37. THOME JF, SEIBEL MJ, SILVERBERG SJ, ROBINS SP, BILEZIKIAN JP: Biochemical markers of bone metabolism. Zeitschr Rheumatol 50, 133-141, 1991